This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated
Clinical trial NCT03414008 · TERMINATED
Trial details
- NCT number
- NCT03414008
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-05
- Primary completion
- 2019-11-18
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.